I’m Aware That I’m Rare: Sheila Gujrathi, MD and Larry Zisman, MD (341)

The phaware® interview

Sheila Gujrathi, MD and Larry Zisman, MD of Gossamer Bio discuss the development of an investigational new treatment for pulmonary arterial hypertension and their Phase 2 Clinical Trial for GB0002.

Learn more about their Clinical Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension (PAH): https://clinicaltrials.gov/ct2/show/NCT03926793